14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $20.02 $22.05 Wednesday, 28th Feb 2024 EXEL stock ended at $21.91. This is 0.92% more than the trading day before Tuesday, 27th Feb 2024. During the day the stock fluctuated 2.54% from a day low at $21.49 to a day high of $22.04.
90 days $19.21 $24.34
52 weeks $16.15 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
2024-02-28 $21.64 $22.04 $21.49 $21.91 2 351 030
2024-02-27 $21.97 $22.03 $21.61 $21.71 2 483 700
2024-02-26 $21.49 $21.99 $21.49 $21.96 2 173 763
2024-02-23 $21.29 $21.78 $21.15 $21.53 2 637 810
2024-02-22 $20.72 $20.88 $20.49 $20.71 1 782 677
2024-02-21 $20.59 $20.78 $20.57 $20.72 1 945 930
2024-02-20 $20.45 $20.81 $20.43 $20.63 1 944 591
2024-02-16 $20.56 $20.84 $20.38 $20.48 2 388 570
2024-02-15 $20.52 $20.91 $20.44 $20.59 2 360 934
2024-02-14 $20.27 $20.58 $20.22 $20.39 2 035 411
2024-02-13 $20.30 $20.69 $20.16 $20.23 2 455 678
2024-02-12 $20.24 $20.44 $20.02 $20.39 3 437 528
2024-02-09 $20.30 $20.42 $20.11 $20.22 2 269 146
2024-02-08 $20.18 $20.67 $20.12 $20.17 3 078 642
2024-02-07 $21.09 $21.21 $20.15 $20.18 3 375 190
2024-02-06 $21.36 $21.90 $21.36 $21.83 1 908 528
2024-02-05 $21.29 $21.54 $21.18 $21.40 1 162 283
2024-02-02 $21.75 $21.75 $21.36 $21.49 1 171 086
2024-02-01 $21.75 $21.88 $21.54 $21.75 1 442 866
2024-01-31 $21.93 $22.05 $21.75 $21.76 1 482 263
2024-01-30 $21.97 $22.01 $21.73 $21.89 2 144 015
2024-01-29 $21.89 $22.01 $21.82 $21.89 1 472 250
2024-01-26 $22.30 $22.37 $22.04 $22.12 1 132 057
2024-01-25 $22.14 $22.45 $21.85 $22.09 2 787 275
2024-01-24 $22.61 $22.70 $22.06 $22.11 2 657 751
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT